Product information

Xolair 150 mg
6 x 1 ml
omalizumab
4227609
5.57 / 10
Locked

Product properties

242138-07-4
R03DX05
Novartis Europharm
Solution for injection
€1,114.60
EU/1/05/319/026
07613421110000
M42
Public
662009-01

Pharmacist Assessment

Discontinued product — remaining stock available

The commercialization of this product has been stopped (reason: Replacement by another medicinal product/pack), but remaining stock is available at wholesalers (score 5.57/10). This stock will not be replenished. Plan the switch to an alternative.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 13 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Replacement by another medicinal product/pack

Alternative available

Composition

2 ingredients

Substance Type Strength CAS
Active ingredient
150 mg/mL
242138-07-4
Excipient

Additional information

Availability statistics

Commercialization stopped
364 days
3
0
04/04/2025